Line-field confocal optical coherence tomography for monitoring intralesional immunotherapy with L19IL2/L19TNF (daromun) in recurrent basal cell carcinoma

Lignende værker

• Intralesional L19IL2/L19TNF in high-risk lacSCC patients: results from the Phase II DUNCAN Trial Exploratory Cohort
  af: T. Eigentler, et al.
  Udgivet: (2026-01-01)
• Abscopal effect of intratumoral therapy with daromun in locally advanced and lymphogenically metastasised malignant melanoma
  af: J. Schulte, et al.
  Udgivet: (2026-01-01)
• Efficacy and safety of daromun as neoadjuvant intralesional immunotherapy in locally advanced, resectable melanoma: experiences from a compassionate use program
  af: C. Straub, et al.
  Udgivet: (2026-01-01)
• Line-field confocal optical coherence tomography for monitoring intralesional immunotherapy with L19IL2/L19TNF (daromun) in recurrent basal cell carcinoma
  af: M.F. Vera Morandini, et al.
  Udgivet: (2026-01-01)
• CDA deficiency is not associated with higher sensitivity to immune checkpoint inhibitors in melanoma patients
  af: C. Gaudy-Marqueste, et al.
  Udgivet: (2024-12-01)